Note: a word of caution, this is one study and as the article points out people with hepatitis C should have their zinc levels checked out before adding zinc supplements to their diet.
A great deal of current research in the area of hepatitis C virus (HCV) centers on the complex mechanisms by which to disrupt or prevent infection. Not surprisingly, the research and the resulting treatments are extremely costly.
Recently, Scott Read, PhD, a researcher at the Storr Liver Centre at The Westmead Institute for Medical Research in Australia, and several colleagues focused their attention instead on a much smaller target: liver cells and their components. Their research has the potential to add a less expensive adjunctive therapy to improve current HCV regimens.
Metallothioneins (MTs), the primary intracellular zinc-binding proteins, are responsible for zinc homeostasis and a number of intracellular functions, including heavy metal detoxification and scavenging of free radicals.